Methyl 2-(difluoromethyl)-3-fluoroisonicotinate

Catalog No.: 
ACIZVA955
CAS No.: 
1379375-21-9
Molecular Formula: 
C8H6F3NO2
Molecular Weight: 
205.13
Methyl 2-(difluoromethyl)-3-fluoroisonicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$238.00InquiryInquiry
250mg97%$451.00InquiryInquiry
1g97%$1127.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(difluoromethyl)-3-fluoroisonicotinate
IUPAC Namemethyl 2-(difluoromethyl)-3-fluoroisonicotinate
MDL No.MFCD25480272
Molecular FormulaC8H6F3NO2
Molecular Weight205.13
SMILESO=C(OC)C1=CC=NC(C(F)F)=C1F
InChI KeyLUEAKEOFBGQUKH-UHFFFAOYSA-N
Synonym4-Pyridinecarboxylic acid, 2-(difluoromethyl)-3-fluoro-, methyl ester
CAS No.1379375-21-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIZVA955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIZVA955 route product structure diagram
    ACIZVA9551379375-21-9
Inquiry

2. ACIZVA955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIZVA955 route product structure diagram
    ACIZVA9551379375-21-9
Inquiry

3. ACIZVA955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIZVA955 route product structure diagram
    ACIZVA9551379375-21-9
Inquiry

Comments (0)